The biotech industry has optimized for speed, for optics, for reassurance. We have built systems that prioritize the appearance of progress and the promise of delivery over the clarity of intent and the accuracy of execution. The Age of Accountability is a reset. It demands clarity of intent: what are we actually trying to achieve? It demands explicit ownership: who is responsible for what? It demands delivery that matches promise. Speed without control is not acceleration. It is crash risk. Many failures are not scientific failures. They are execution failures in the gaps between intent, decision, and delivery. Accountability and empathy are complementary, not opposed. Tools are inputs to judgment, not substitutes for it. Governance is a design system, not a bureaucratic obstacle.
Key Takeaways
Key Takeaways
- The biotech industry has optimized for speed and optics at the cost of clear intent and executable strategy. The Age of Accountability resets these priorities.
- Clarity of intent means knowing what you are building and why. Explicit ownership means assigning responsibility for execution. Delivery that matches promise means doing what you said you would do.
- Speed without control is crash risk, not acceleration. Kieran Engels and Seuss+ help teams align pace with capability and build controls that enable confident decision-making.
- Many clinical failures attributed to science are actually execution failures: unclear accountability, poor handoffs, unexamined assumptions, gaps between decision and delivery.
- Governance enables accountability by creating clarity in decision-making, responsibility assignment, and delivery verification.
The Illusion of Speed
We have been taught to optimize for speed. Faster timelines. Faster decisions. Faster approval. But speed without control creates risk. A trial that moves fast but loses data integrity is not a success. A program that accelerates but loses track of what was promised is not progress. The illusion of speed comes from decoupling pace from accountability.
Accountability requires clarity. What are we committing to? Who is responsible if we miss? What are we assuming will go right? What is our contingency if assumptions break?
Execution Failure vs. Scientific Failure
When clinical programs fail, the default assumption is science. The drug did not work. The design was flawed. But many failures are execution failures. Poor handoffs between teams. Unclear accountability for decisions. Vendors operating without clear requirements. Requirements that vendors cannot actually meet.
What We Optimized For vs. What Accountability Requires
| What We Optimized For | What Accountability Requires |
| Speed | Pace aligned with control capability |
| Optics (appearance of progress) | Accuracy of execution |
| Reassurance | Clarity of intent and explicit ownership |
| Avoiding difficult questions | Examining assumptions before execution |
| Tools as substitutes for judgment | Tools as inputs to judgment |
Building for Accountability
Accountability starts with clarity. What is the decision? Who made it? On what basis? What conditions would make us revisit it? These questions are not obstacles to speed. They are the foundation of confident speed.
Kieran Engels works with sponsors to build systems that embed accountability into governance. Not as punishment, but as clarity. When roles are explicit, decisions are documented, and assumptions are tested, teams move faster because they move with confidence.
Learn more about how Seuss+ helps teams build governance systems at seuss.plus/clinical-trial-vendor-optimization-services/.
Speed without control is crash risk. Accountability is not an obstacle to progress. It is the foundation of confident acceleration.
Key Industry Data
The FDA formally adopted ICH E6(R3) on September 9, 2025, replacing the previous Good Clinical Practice framework with a risk based, proportionate oversight model. (Source: FDA)
The MHRA has classified ICH E6(R3) adoption as a major event in GCP, signaling that inspection criteria will shift toward Quality by Design assessment. (Source: MHRA)
Only 11.8% of drugs entering clinical testing ultimately receive regulatory approval, underscoring the cost of governance failures compounding scientific uncertainty. (Source: Tufts CSDD)
FDA warning letters surged 59% year over year in FY2025, from 190 to 303, reflecting heightened regulatory enforcement across the industry. (Source: FDA)
Trial delays cost sponsors $600,000 to $8 million per day, making accountability gaps not just a compliance risk but a direct financial exposure. (Source: Tufts CSDD)
Frequently Asked Questions
No. Blame is backward-looking and punitive. Accountability is forward-looking and clarifying. It assigns responsibility for decisions and delivery so teams know what to expect and what is expected of them.
By making accountability about clarity, not consequences. Document the decision, the assumptions, the rationale. When something breaks, learn why. Did the assumption fail? Did the execution miss? Was the decision wrong? This investigation is diagnostic, not punitive.
No, it accelerates it. When people know the decision will be documented and assumptions will be tested, they make decisions faster and more confidently. They do not second-guess as much because the framework is clear.
Empathy means understanding the constraints and pressures people face. Accountability means being clear about expectations despite those constraints. They are complementary. You can be empathetic about challenges and accountable about delivery.
Through governance design. We help teams clarify decision criteria, assign responsibility, document assumptions, and create verification points. This creates the structure in which accountability can flourish.
About the Author
Kieran Engels is CEO and Co-Founder of Seuss+, a strategy and execution partner helping biotech sponsors optimize vendor relationships across clinical development. With more than a decade of experience in vendor governance, risk management, and clinical trial execution, Kieran works with biotech leadership teams to build the oversight systems that protect timelines, budgets, and data integrity. Learn more at seuss.plus.
